Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myelomaChristian Neelsen, Niels Weinhold, Daniel Paech et al.|European Radiology|2024Cited by 2
P-011 Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/ refractory multiple myeloma are associated with pre-CAR-T bridging therapiesJan Frenking, Marc S. Raab, Joseph Kauer et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
P-482 Dietary habits correlate with myeloma pathogenesis and treatment outcome in multiple myelomaLilli Sester, Marc S. Raab, Anna Katharina Gambihler et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0